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We want to provide an online CE course. Would you please take a few minutes to answer this




 Drug Shortages: Additional News and Information
DRUG
 New Drug Product: Brineura
 Lupin intros generic Vigamox
 Perrigo launches generic Axiron
 Teva intros 2 new strengths of ADHD generic
 New Drug Product: Alunbrig
HOSPITAL
 Providers battle ‘fake’ healthcare news
FDA
 New Antibiotic Baxdela Gets FDA Approval
 FDA Approves New ADHD Treatment Option
 Endo to Pull Opana From the Market Following
FDA Request
 The 5 Latest FDA Drug Approvals
 FDA Approves New Option for SLE
 Opioid Pulled From Market Following FDA Request
 Report Calls on FDA to Adopt New Standard for
Reviewing Opioids
 FDA approves 2 more dosage strengths of Impax’s
Focalin XR generic
 FDA Updates on Multistate Outbreak of
Burkholderia cepacia Infections
 MedWatch: The FDA Safety Information and
Adverse Event Reporting Program
IMMUNIZATIONS
 Quiz: How Much Do You Know About Vaccination?
 Vaccination may be curbing ER visits for shingles
 Self-Administered 'Patch' Vaccines May Soon
Become Reality
 Vaccine Information Statements (VISs)
 Announcement: Implementation of the Vaccine
Adverse Event Reporting System 2.0 Reporting
Form
 Parents, Get Your Teens Their Vaccines!
 High-Dose Flu Vaccine Improves Outcomes in
Elderly Patients
 Monitoring Pneumococcal Vaccine Administration
in Older Adults
 Vaccine Information Statements (VISs)




 Pharmacist Expertise in Alzheimers May Be
Overlooked
 Demise of the Traditional Syringe and Rise of the
Smart Syringe System
 New CDC report: More than 100 million Americans
have diabetes or prediabetes
 Blood Sugar Swings Tied to Depression in Elderly
With Type 2 Diabetes
 Trump’s Executive Order on Drug Pricing Expected
to be Pharma-Friendly
 Drug Prices: Could Taxing Sharp Increases Impact
Costs?
 Malaria drug protects fetal mice from Zika virus,
NIH-funded study finds
 DEA clarifies guidance on forwarding unfilled e-
prescribed controlled substances
 Opioid Reduction Strategies Could Improve Pain,
Quality of Life
 "Serious" Risks Seen with Stopping Therapy After a
Statin-Related Adverse Event
 Extended Use Dates Provided by Pfizer to Assist

























07/11/2017 Andropharm Sten Z and M1 Alphas capsules Unapproved drug Andropharm














Inc. d/b/a Avella of
Houston
06/17/2017 Bristol-MyersSquibb Eliquis (apixaban) 5 mg Tablets Tablet Mix-Up Bristol-Myers Squibb
06/16/2017 Alvogen Clindamycin Injection USP Lack of sterilityassurance Alvogen
06/15/2017 Hospira
8.4% Sodium Bicarbonate Injection, USP, NeutTM (Sodium
Bicarbonate 4% additive solution), QUELICINTM










 Drug Shortages: Additional News and Information
o https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm349561.htm2016-
DRUG




 Lupin intros generic Vigamox
o http://www.drugstorenews.com/article/lupin-intros-generic-vigamox?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2d-60scI-
dsYq&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 Perrigo launches generic Axiron
o http://www.drugstorenews.com/article/perrigo-launches-generic-axiron?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2i-60scI-
2IpHuE&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 Teva intros 2 new strengths of ADHD generic
o http://www.drugstorenews.com/article/teva-intros--new-strengths-adhd-generic?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2k-60scI-
gPUYI&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142















 FDA Approves New ADHD Treatment Option
o http://www.consultant360.com/exclusives/fda-approves-new-adhd-treatment-option






 The 5 Latest FDA Drug Approvals
o http://drugtopics.modernmedicine.com/drug-topics/news/5-latest-fda-drug-approvals?GUID=EC22DC7A-8C9E-4231-BAFB-
C4E25C30003B&rememberme=1&ts=18072017
 FDA Approves New Option for SLE
o http://www.consultant360.com/exclusives/fda-approves-new-option-sle
 Opioid Pulled From Market Following FDA Request
o http://www.consultant360.com/exclusives/opioid-pulled-market-following-fda-request
 Report Calls on FDA to Adopt New Standard for Reviewing Opioids
o http://www.raps.org/Regulatory-Focus/News/2017/07/14/28087/Report-Calls-on-FDA-to-Adopt-New-Standard-for-Reviewing-
Opioids/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz%2DEmails
 FDA approves 2 more dosage strengths of Impax’s Focalin XR generic
o http://www.drugstorenews.com/article/fda-approves--more-dosage-strengths-impaxs-focalin-xr-generic?tp=i-H55-Q5U-3tl-60vGQ-1v-
1qda-1c-z2m-60scI-D5XYU&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142




 MedWatch: The FDA Safety Information and Adverse Event Reporting Program
o https://www.fda.gov/Safety/MedWatch/default.htm
IMMUNIZATIONS
 Quiz: How Much Do You Know About Vaccination?
o http://drugtopics.modernmedicine.com/drug-topics/news/quiz-how-much-do-you-know-about-vaccination?GUID=EC22DC7A-8C9E-4231-
BAFB-C4E25C30003B&rememberme=1&ts=21062017
 Vaccination may be curbing ER visits for shingles
o http://www.reuters.com/article/us-health-shingles-er-visits-idUSKBN19I2S7




 Vaccine Information Statements (VISs)
o https://www.cdc.gov/vaccines/hcp/vis/index.html
 Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form
o https://www.cdc.gov/mmwr/volumes/66/wr/mm6627a5.htm
 Parents, Get Your Teens Their Vaccines!
o https://consumer.healthday.com/kids-health-information-23/immunization-news-405/parents-get-your-teens-their-vaccines-724574.html
 High-Dose Flu Vaccine Improves Outcomes in Elderly Patients
o http://www.consultant360.com/exclusives/high-dose-flu-vaccine-improves-outcomes-elderly-patients
 Monitoring Pneumococcal Vaccine Administration in Older Adults
o http://www.managedhealthcareconnect.com/content/monitoring-pneumococcal-vaccine-administration-older-adults
 Vaccine Information Statements (VISs)
o https://www.cdc.gov/vaccines/hcp/vis/index.html




 Pharmacist Expertise in Alzheimers May Be Overlooked
o http://www.managedhealthcareconnect.com/content/pharmacist-expertise-alzheimers-may-be-overlooked
 Demise of the Traditional Syringe and Rise of the Smart Syringe System
o http://www.consultant360.com/content/demise-traditional-syringe-and-rise-smart-syringe-system
 New CDC report: More than 100 million Americans have diabetes or prediabetes
o https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
 Blood Sugar Swings Tied to Depression in Elderly With Type 2 Diabetes
o http://www.managedhealthcareconnect.com/content/blood-sugar-swings-tied-depression-elderly-type-2-diabetes
 Trump’s Executive Order on Drug Pricing Expected to be Pharma-Friendly
o http://www.managedhealthcareconnect.com/content/trump-s-executive-order-drug-pricing-expected-be-pharma-friendly
 Drug Prices: Could Taxing Sharp Increases Impact Costs?
o http://www.managedhealthcareconnect.com/article/drug-prices-could-taxing-sharp-increases-impact-costs
 Malaria drug protects fetal mice from Zika virus, NIH-funded study finds
o https://www.nih.gov/news-events/news-releases/malaria-drug-protects-fetal-mice-zika-virus-nih-funded-study-finds
 DEA clarifies guidance on forwarding unfilled e-prescribed controlled substances
o http://www.drugstorenews.com/article/dea-clarifies-guidance-forwarding-unfilled-e-prescribed-controlled-substances
 Opioid Reduction Strategies Could Improve Pain, Quality of Life
o http://www.consultant360.com/exclusives/opioid-reduction-strategies-could-improve-pain-quality-life
 "Serious" Risks Seen with Stopping Therapy After a Statin-Related Adverse Event
o http://www.jwatch.org/fw113131/2017/07/25/serious-risks-seen-with-stopping-therapy-after-
statin?query=pfwTOC&jwd=000020097761&jspc
 Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages
o https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm
